United Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for United Therapeutics

Access the complete profile.

United Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 4234 Professional & Commercial Equipment & Supplies Merchant Wholesalers
Address	1040 Spring Street Silver Spring, MD 20910

United Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • United Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • United Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

United Therapeutics is a publicly traded company on NMS using the ticker symbol UTHR. Detailed information on company financials and operating reports can be found here: NMS: UTHR

United Therapeutics Annual Revenue and Growth Rate

United Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: United Therapeutics's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that United Therapeutics is developing and marketing. United Therapeutics doesn't have any recent trademark applications, indicating United Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SOFTASO Drug delivery pumps; Nebulizers for administering medication in the form of a mist inhaled into the lungs, for treatment of pulmonary hypertension and heart and lung diseases.	12/15/2023
ORGANICE Medical devices, namely, transport coolers for use in the cold storage of organs for transplant	10/02/2023
PROPARI PUMP FOR REMODULIN (TREPROSTINIL) INJECTION Drug delivery systems sold empty, namely, drug delivery pumps	06/29/2022

See all trademarks and details in the Full Report.

Market Share of United Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as United Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to United Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
UNITED THERAPEUTICS	Silver Spring, MD	100
LUMINA CORPS	Silver Spring, MD	2
AUTONOMOUS THERAPEUTICS	Silver Spring, MD	2
COOLCAD ELECTRONICS	Takoma Park, MD	1
DELTARES USA	Silver Spring, MD	1
SAZE TECHNOLOGIES	Silver Spring, MD	1

Future Competition: United Therapeutics's Fastest Growing Competitors

These companies are in the same general field as United Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)